To include your compound in the COVID-19 Resource Center, submit it here.

Galena plummets after halting NeuVax study

Galena Biopharma Inc. (NASDAQ:GALE) lost $1.68 (83%) to $0.35 on Wednesday after it said it

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE